期刊文献+

原发性醛固酮增多症左心室肥厚及相关影响因素分析 被引量:3

Increased left ventricular mass and its associated factors in patients with primary aldosteronism
原文传递
导出
摘要 目的探讨原发性醛固酮增多症(原醛)患者的并发症情况,分析原醛患者左心室肥厚的相关因素。方法对93例原发性醛固酮增多症(原醛组)患者及同期住院的84例原发性高血压(原高组)患者的临床资料进行回顾性分析。结果(1)与原高组患者相比,原醛组患者血钙水平更低(P〈0.05),但脂代谢异常程度较轻。(2)原醛组患者左心室肥厚较原高组患者严重,相关分析显示,原醛组患者的左心室质量与低血钾病程(r=0.983,P〈0.01)、立位醛固酮水平(r=0.993,P〈0.01)呈显著正相关,而与血钾(r=-0.993,P〈0.01)呈显著负相关。结论原醛组患者与原高组患者相比血钙水平更低,左心室肥厚更严重,但脂代谢异常程度较轻;原醛组患者的左心室质量与低血钾病程、立位醛固酮水平和血钾水平具有相关性。 Objectives The aim of this study was to evaluate the cormorbidities in patients with primary aldosteronism(PA) and to explore the factors associated with left ventricular hypertrophy(LVH) in patients with PA. Methods We retrieved records of 93 cases with PA and 84 controls with essential hypertension (EH). Results ( 1 ) Compared with EH, the plasma calcium level was lower in patients with PA(P 〈0.05 ). However, the patients with EH had severer dyslipidemia,manifesting as higher levels of TG ,LDL,Apo-A1 and Apo-B (all P 〈 0.05 ). (2)The patients with PA had severer left ventricular hyper- trophy compared with the patients with EH with a larger left ventrieular end - diastolic dimension (LVEDd). Correlation analysis demonstrated a correlation between the left ventrieular mass(LVM) and duration of hypokalemia, plasma potassium and plasma aldosterone( upright position) in patients with PA. Conclusion Patients with PA had lower plasma calcium and severer left ventricular hypertrophy. The left ventricular mass of patients with PA was correlated with duration of hypokalemia, plasma potassium and plasma aldosterone (upright).
出处 《临床内科杂志》 CAS 2011年第10期668-671,共4页 Journal of Clinical Internal Medicine
关键词 原发性醛固酮增多症 血钙 脂代谢 左心室肥厚 Primary aldosteronism Plasma calcium Lipid metabolism Leftventricular hypertrophy
  • 相关文献

同被引文献28

  • 1杜昕,易宗春,戴闺柱.血管紧张素Ⅱ和醛固酮对心脏成纤维细胞Ⅲ型胶原mRNA表达的影响[J].中华老年心脑血管病杂志,2000,2(1):45-47. 被引量:6
  • 2王文.《中国高血压防治指南》2005年修订版要点解读[J].中国实用乡村医生杂志,2007,14(10):47-52. 被引量:60
  • 3PalmieriV, Celentano A, Roman MJ, et al. Fibrinogen and preclinical eehocardiographic target organ damage:the strong heart study [ J ]. Hypertension,2001,38 (5) : 1068-1074.
  • 4Schroeder AP,Sihm I, Morn B, et al. Influence of humoral and neurohormonal factors on cardiovascular hypertrophy in untreated essential hypertensives [J]. Am J Hypertens, 1996,9 ( 3 ) : 207- 215.
  • 5Catena C, Colussi G, Marzano L, et al. Aldosterone and the heart: from basic research to clinical evidence [J]. Horm Metab Res, 2012,44(3) :181-187.
  • 6Catena C, Colussi GL, Marzano L, et al. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism[J]. Horm Metab Res,2012,44(3 ) :188-193.
  • 7Arnett DK, McClelland RL, Bank A, et al. Biomarkers of inflammation and hemostasis associated with left ventricular mass: The Multiethnic Study of Atherosclerosis (MESA) [ J ]. Int J Mol Epidemiol Genet ,2011,2 (4) :391-400.
  • 8Rosell6-Llet E, Rivera M, Martinez-Dolz L, et al. Inflammatory activation and left ventricular mass in essential hypertension [ J]. Am J Hypertens, 2009,22 (4) : 444 -450.
  • 9MULATERO P, STOWASSER M, LOH K C, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents [J]. J CLin Endoerinol Metab, 2004, 89 ( 3 ) : 1045-1050.
  • 10ROSSI G P, BERNINI G, CALIUMI C, et al. A prospeelive stud}' ff the prevalene ,f primary aldoste'nism n 1,125 hypertensive patients [J]. J Am Coll Cardiol, 2006, 48 (11): 2293-2300.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部